Iloprost, a stable analogue of PGI2: clinical results and pathophysiological considerations.
Stock
G
G
Research Laboratories of Schering AG, Berlin, West Germany.
Müller
B
B
Krais
T
T
Schillinger
E
E
D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000503:physiopathology; D001792:Blood Platelets / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D007962:Leukocytes / Q000187:drug effects; D008833:Microcirculation / Q000187:drug effects; D013927:Thrombosis / Q000188:drug therapy
D016285:Iloprost